Avrobio Developing a Gene Therapy for Pompe Disease – Rare Disease Report
Rare Disease Report |
Avrobio Developing a Gene Therapy for Pompe Disease
Rare Disease Report This will be the third gene therapy the company has in its pipeline to treat a rare lysosomal storage disease; the other 2 programs are for Fabry disease and Gaucher disease. The company is especially invested in lysosomal storage diseases, as it has a … AVROBIO, Inc. Expands Rare Disease Pipeline with Gene Therapy to Treat Pompe Disease |
